Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Northwest Biotherapeutics (NWBO) Asset Utilization Ratio (2016 - 2025)

Northwest Biotherapeutics (NWBO) has 15 years of Asset Utilization Ratio data on record, last reported at 0.03 in Q3 2025.

  • For Q3 2025, Asset Utilization Ratio fell 43.84% year-over-year to 0.03; the TTM value through Sep 2025 reached 0.03, down 43.84%, while the annual FY2024 figure was 0.05, 22.45% down from the prior year.
  • Asset Utilization Ratio reached 0.03 in Q3 2025 per NWBO's latest filing, down from 0.04 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.07 in Q3 2023 and bottomed at 0.03 in Q1 2021.
  • Average Asset Utilization Ratio over 5 years is 0.05, with a median of 0.05 recorded in 2024.
  • Peak YoY movement for Asset Utilization Ratio: crashed 88.97% in 2021, then skyrocketed 103.84% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.03 in 2021, then soared by 83.45% to 0.05 in 2022, then grew by 20.72% to 0.07 in 2023, then decreased by 24.25% to 0.05 in 2024, then plummeted by 36.83% to 0.03 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.03 in Q3 2025, 0.04 in Q2 2025, and 0.05 in Q1 2025.